HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
NCT06425848
This study is recruiting at 11 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Heart Failure
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Kansas Medical Center
- Last updated on ClinicalTrials.gov
- May 22, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Scripps Health · La Jolla, CA
Indiana · 1
- Indiana University · Bloomington, IN
Kansas · 1
- University of Kansas Medical Center · Kansas City, KS
Minnesota · 1
- Minneapolis Heart Institute Foundation/ Allina Health · Minneapolis, MN
Missouri · 1
- Saint Luke's Health System · Kansas City, MO
North Carolina · 1
- University of North Carolina/ Rex Hospital, Inc. · Raleigh, NC
Oregon · 1
- Providence Heart Institute · Portland, OR
South Carolina · 1
- Prisma Health · Columbia, SC
South Dakota · 1
- Sanford Health · Sioux Falls, SD
Texas · 2
- Austin Heart · Austin, TX
- Houston Methodist DeBakey Heart and Vascular Center · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.